Literature DB >> 7667317

p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts.

M L Agarwal1, A Agarwal, W R Taylor, G R Stark.   

Abstract

Increased expression of wild-type p53 in response to DNA damage arrests cells late in the G1 stage of the cell cycle by stimulating the synthesis of inhibitors of cyclin-dependent kinases, such as p21/WAF1. To study the effects of p53 without the complication of DNA damage, we used tetracycline to regulate its expression in MDAH041 human fibroblasts that lack endogenous p53. When p53 is expressed at a level comparable to that induced by DNA damage in other cells, most MDAH041 cells arrested in G1, but a significant fraction also arrested in G2/M. Cells released from a mimosine block early in S phase stopped predominantly in G2/M in the presence of p53, confirming that p53 can mediate arrest at this stage, as well as in G1. In these cells, there was appreciable induction of p21/WAF1. MDAH041 cells arrested by tetracycline-regulated p53 for as long as 20 days resumed growth when the p53 level was lowered, in striking contrast to the irreversible arrest mediated by DNA damage. Therefore, irreversible arrest must involve processes other than or in addition to the interaction of p53-induced p21/WAF1 with G1 and G2 cyclin-dependent kinases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7667317      PMCID: PMC41183          DOI: 10.1073/pnas.92.18.8493

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.

Authors:  L R Livingstone; A White; J Sprouse; E Livanos; T Jacks; T D Tlsty
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

2.  Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase.

Authors:  D Lin; M T Shields; S J Ullrich; E Appella; W E Mercer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

3.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

4.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

5.  Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein.

Authors:  J Martinez; I Georgoff; J Martinez; A J Levine
Journal:  Genes Dev       Date:  1991-02       Impact factor: 11.361

Review 6.  Universal control mechanism regulating onset of M-phase.

Authors:  P Nurse
Journal:  Nature       Date:  1990-04-05       Impact factor: 49.962

7.  Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53.

Authors:  D Michalovitz; O Halevy; M Oren
Journal:  Cell       Date:  1990-08-24       Impact factor: 41.582

8.  Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.

Authors:  Y Yin; M A Tainsky; F Z Bischoff; L C Strong; G M Wahl
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

9.  Participation of p53 protein in the cellular response to DNA damage.

Authors:  M B Kastan; O Onyekwere; D Sidransky; B Vogelstein; R W Craig
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

Review 10.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

View more
  222 in total

1.  p53 down-regulates CHK1 through p21 and the retinoblastoma protein.

Authors:  V Gottifredi; O Karni-Schmidt; S S Shieh; C Prives
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

2.  The G(2) checkpoint is maintained by redundant pathways.

Authors:  T M Passalaris; J A Benanti; L Gewin; T Kiyono; D A Galloway
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

3.  Repression of CDK1 and other genes with CDE and CHR promoter elements during DNA damage-induced G(2)/M arrest in human cells.

Authors:  C Badie; J E Itzhaki; M J Sullivan; A J Carpenter; A C Porter
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

4.  p53 regulation of G(2) checkpoint is retinoblastoma protein dependent.

Authors:  P M Flatt; L J Tang; C D Scatena; S T Szak; J A Pietenpol
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

5.  Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions.

Authors:  J H Dannenberg; A van Rossum; L Schuijff; H te Riele
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

6.  Proapoptotic p53-interacting protein 53BP2 is induced by UV irradiation but suppressed by p53.

Authors:  C D Lopez; Y Ao; L H Rohde; T D Perez; D J O'Connor; X Lu; J M Ford; L Naumovski
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

7.  Cell proliferation and DNA breaks are involved in ultraviolet light-induced apoptosis in nucleotide excision repair-deficient Chinese hamster cells.

Authors:  Torsten R Dunkern; Bernd Kaina
Journal:  Mol Biol Cell       Date:  2002-01       Impact factor: 4.138

8.  Demethylating agent 5-aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agents.

Authors:  Sameer Mirza; Gayatri Sharma; Pranav Pandya; Ranju Ralhan
Journal:  Mol Cell Biochem       Date:  2010-05-09       Impact factor: 3.396

9.  Nijmegen breakage syndrome cells fail to induce the p53-mediated DNA damage response following exposure to ionizing radiation.

Authors:  W Jongmans; M Vuillaume; K Chrzanowska; D Smeets; K Sperling; J Hall
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

10.  Alteration of Drug Sensitivity in Human Colon Cancer Cells after Exposure to Heat: Implications for Liver Metastasis Therapy using RFA and Chemotherapy.

Authors:  Ryouji Makizumi; Weng-Lang Yang; Randall P Owen; Rohit R Sharma; T S Ravikumar
Journal:  Int J Clin Exp Med       Date:  2008-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.